RNA Outsourcing Resources
-
Investors Trust Strong Supply Chains
3/2/2026
Investors now value operational maturity as much as science. Early, intentional supply‑chain planning shows scalability, lowers risk, and builds confidence in reliable growth.
-
Writing Effective Clinical Regulatory Documents For Therapy Trials
7/11/2025
Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.
-
Accelerate LNP Manufacturing With Automated Process Development
2/5/2026
Manual LNP formulation introduces process variability that threatens particle quality and yield. As programs scale toward clinical production, maintaining strict control over CQAs becomes essential.
-
The Shift Toward Flexible FSP Models
11/13/2025
Flexible FSP models are reshaping clinical outsourcing by offering sponsors scalable, cost-predictable partnerships that preserve control, enhance quality, and support long-term strategic goals.
-
Phase IIb Trial: Evaluating A Novel Treatment For Locally Advanced Or Metastatic Breast Cancer
12/5/2024
This case study highlights a successful Phase IIb clinical trial conducted by an Indian biotech company evaluating a novel treatment for Locally Advanced or Metastatic Breast Cancer.
-
Securing INmune Bio's Trial Materials In A Crisis
6/26/2025
Discover how a sudden biostorage shutdown put INmune Bio’s trial at risk, revealing the critical importance of logistics and rapid coordination in protecting advanced therapy programs.
-
Moving CGTx Clinical Development Forward In 2023
6/27/2023
Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.
-
Accelerate Efficiency By Decoupling Collection From Manufacturing
6/26/2026
Cryopreservation eliminates rigid timelines by decoupling collection from production, providing the flexibility needed to optimize facility use and stabilize advanced therapy supply chains.
-
Hidden Risks In Your Supply Chain: Regulatory Support Can Save Your CGT
10/20/2025
Unvalidated shipping lanes and incomplete documentation can cause regulatory delays. Proactive qualification and risk assessments are vital for compliance and safeguarding product integrity.
-
Transcribing RNA With Higher Purity, Activity While Using Less Cap Analog
2/11/2025
Enhance RNA manufacturing with HiCap T7 RNA Polymerase, which minimizes dsRNA, boosts expression, and reduces capping costs for superior therapeutic development.